NXNN

Nexeon Medsystems Inc Stock Price

OTCPK:NXNN Community·US$203.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NXNN Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

NXNN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

3 Risks
0 Rewards

Nexeon Medsystems Inc Key Details

US$9.8m

Revenue

US$7.1m

Cost of Revenue

US$2.7m

Gross Profit

US$4.4m

Other Expenses

-US$1.7m

Earnings

Last Reported Earnings
Sep 30, 2018
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About NXNN

Founded
2015
Employees
n/a
CEO
William Rosellini
WebsiteView website
www.nexeonmedsystems.com

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson’s disease in the United States, as well as for Parkinson’s disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Recent NXNN News & Updates

No updates

Recent updates

No updates